Articles related to STROKE
Risk for Myocardial Infarction (MI), Stroke, and Pulmonary Embolism (PE) Following COVID-19 Vaccines in Adults Younger Than 75 Years in France
To assess short-term risk for severe cardiovascular events (excluding myocarditis and pericarditis) after COVID-19 vaccination, adults younger than 75 years hospitalized for PE, acute MI, hemorrhagic stroke, or ischemic stroke (73,325 events) were reviewed in relation to a 1st or 2nd COVID vaccine dose. No association was found between the Pfizer–BioNTech or Moderna vaccine and severe cardiovascular events. The first dose of the Oxford–AstraZeneca vaccine was associated with acute MI and PE in the second week after vaccination. An association with MI in the second week after a single dose of the Janssen vaccine could not be ruled out.
Cardiology September 6th 2022
Left Atrial Appendage Occlusion Versus Oral Anticoagulation in Atrial Fibrillation
What is the best strategy for preventing stroke in patients with non-valvular AF: anticoagulants or left atrial appendage occlusion (LAAO)? The answer depends on the individual patient’s combination of stroke and bleeding risks. In this study, combined risks favored LAAO for higher bleeding risk, but that benefit became less certain at higher stroke risks.
Cardiology August 23rd 2022
Why Experts Should Rethink the Cookie Theft Picture for Stroke Evaluation
Since 1972, clinicians have used the Cookie Theft image to assist them diagnose speech and language problems as well as spatial and visual anomalies. However, a position presented in the Journal of the American Medical Association – Neurology suggests that frequent exposure to the Cookie Theft image may reduce patients’ self-confidence and undermine their sense of belonging and trust.
Neurology August 8th 2022
One-Year Outcome Trajectories and Factors Associated with Functional Recovery Among Survivors of Intracerebral and Intraventricular Hemorrhage with Initial Severe Disability
Patients who survive severe intracerebral hemorrhage (ICH) and intraventricular hemorrhage (IVH) typically have poor functional outcome in the short term and understanding of future recovery has been limited. These findings indicate that hospital events significantly influenced long-term functional recovery after ICH and IVH, suggesting that aggressive ICH and IVH resolution and prevention of systemic complications and cerebral ischemic injury may promote better outcomes among patients with ICH and IVH with high clinical severity.
Neurology August 2nd 2022
Giant Cell Arteritis Growing More Lethal
Giant cell arteritis (GCA) is one of the most dangerous rheumatologic conditions, and mortality rates among patients with the condition in Canada’s Ontario province has researchers very concerned without any explanation for the recent increases in mortality they documented. MedPage Today shares the report from Arthritis Care & Research.
Rheumatology June 29th 2022
Meta-Analysis Questions Strength of Ties Between Statin-Induced LDL Lowering, CV Outcomes
A meta-analysis published in JAMA Internal Medicine has concluded that the link between statin-induced LDL lowering and reduction of CV outcomes may not be as robust as previously assumed. According to the researchers, the absolute risk reduction associated with statin use for all-cause mortality was 0.8% (95% CI, 0.4-1.2), whereas for MI it was 1.3% (95% CI, 0.9-1.7) and for stroke it was 0.4% (95% CI, 0.2-0.6). Absolute risk reduction figures were slightly higher for secondary prevention than for primary prevention.
Cardiology March 22nd 2022